Convergent Dental: Raises $40M in Series C Funding

Convergent Dental Raises $40M in Series C Funding

• Convergent Dental, a Needham, MA-based developer of a laser to enable anesthesia-free, pain-free dentistry, raised $40M in Series C funding round
• The round was led by Arboretum Ventures, with participation from existing investors, including Long River Ventures and the Gund Foundation
• The company intends to use the funds to expand its product portfolio and increase investment in market development
• Led by Michael Cataldo, Chief Executive Officer, Solea provides a all-tissue laser for dentistry
• This technology enables virtually any cavity to be treated without anesthesia and soft tissue (gum) surgeries to be completed with little to no anesthesia, bleeding or sutures
• The company recently launched Solea Sleep, a painless, non-surgical treatment for snoring that works by tightening tissue in the soft palate in a simple 5-minute treatment